Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Boehringer Reps' Names in Back-Pay Class-Action Suit Will Be Known to Their Bosses
- The Jan. 16 deadline has passed for Boehringer Ingelheim sales reps who want to join the class action suit against their employers for back pay. The question now is, what will be the fate of current BI reps who have signed forms asking for back pay in...
- Blog posts 2009-01-22
Additional Resources
- Schering Reps Win Overtime Ruling; Courts Leaning Against Drug Companies on Back Pay
- A federal court in Connecticut has declared that sales reps for Schering-Plough may be entitled to back pay for the unpaid overtime they have worked. The court ruled that reps are not the kind of sales people who are "exempt" from the Fair Labor Standards Act, and...
- Blog posts 2009-04-08
- Halloween Extra Scary for Boehringer Reps: 860 to See Jobs Axed That Day
- Oct. 31, 2009, is the deadline for 860 Boehringer Ingelheim drug sales reps to lose their jobs, according to a letter filed with the Connecticut Department of Labor image below. Many BI reps have already been notified that they will be laid off. by Jim Edwards
- Blog posts 2009-09-08
- Boehringer Reps Get Legal Victory on Back Pay; Amgen, Serono Reps Could Be Affected
- Sales reps at Boeringer-Ingelheim have won a legal victory that may lead to them being awarded back-pay for all the unpaid overtime they have worked. The ruling, by a federal court in Connecticut, could also affect two related cases involving sales reps at Amgen and Serono. by Jim Edwards
- Blog posts 2009-01-08
- Boehringer Ingelheim Axes 600-900 Drug Sales Reps
- Boehringer Ingelheim will ax between 600 and 900 pharmaceutical sales reps as the company heads over a generic cliff in 2010, according to Pharmagossip and CafePharma. Pharmagossip reported that "600 or more" reps got the ax in a Tuesday morning phonecall. by Jim Edwards
- Blog posts 2009-08-26
- Boeringer Reps' Get Legal Victory on Back Pay; Amgen, Serono Reps Could Be Affected
- Sales reps at Boeringer-Ingelheim have won a legal victory that may lead to them being awarded back-pay for all the unpaid overtime they have worked. The ruling, by a federal court in Connecticut, could also affect two related cases involving sales reps at Amgen and Serono. The suit was filed...
- News items 2009-08-07
- Amgen CEO Sharer: Options? No Thanks. I'll Just Take the Cash.
- The total value of compensation paid to the top five executives at Amgen rose slightly in 2008, to $35.9 million from $34 million in 2007. The team largely met its revenue and EPS goals. This seemingly modest state of affairs came to pass because the team was...
- Blog posts 2009-03-11
- Top 10 Weirdest Pharma Stories of the Month
- Sometimes I come across items that aren't important enough to count as news but are nonetheless too strange to ignore. Thus, I give you the top 10 weirdest drug stories for August: The connection between O.J. and Preparation H. Ever wonder why the orange juice in your...
- Blog posts 2008-08-29
- 'Value of Medicine' plays beyond GSK
- THE VALUE OF Medicine industry reputation initiative pioneered by GlaxoSmithKline is winning adherents at other firms. Eli Lilly & Co. is fielding a four-state pilot program using reps to promote the industry's contributions to public health. Boehringer Ingelheim, Allergan and Purdue Pharma are also employing reps in efforts to turn...
- Research articles 2006-06-01
- << Previous
- page 1 of 1
- Next >>
